The Blood-Brain Barrier in Health and Disease
This session invites research on the blood-brain barrier (BBB) and its role in neuroimmunology, focusing on its dysfunction in disease and advancements in drug delivery across the BBB. Researchers should present findings on how the BBB impacts neuroimmune processes and therapeutic outcomes. Attendees will gain insights into novel approaches to targeting the BBB in treating neuroimmune disorders.
Related Conference of The Blood-Brain Barrier in Health and Disease
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
The Blood-Brain Barrier in Health and Disease Conference Speakers
Recommended Sessions
- Neuroinflammation and Psychiatric Disorders
- Advances in Immunotherapy for Neuroimmune Disorders
- Artificial Intelligence in Neuroimmunology Research
- Autoimmunity in Neurodegenerative Diseases
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases
- Emerging Viral Neuroinfections
- Gene Editing and Neuroimmune Disorders
- Genomics and Precision Medicine in Neuroimmunology
- Immunometabolism in Neuroinflammation
- Innate Immunity in Neurological Diseases
- Molecular Pathways in Neuroimmune Disorders
- Neuroimmune Biomarkers: From Discovery to Clinical Application
- Neuroimmune Mechanisms in CNS Infections
- Neuroimmune Responses to Environmental Triggers
- Neuroimmunology of Aging and Neurodegeneration
- Neuroimmunology of Pain and Neuropathic Conditions
- Neuroinfectious Disease Epidemiology
- Role of Microglia in Neuroimmunology
- The Blood-Brain Barrier in Health and Disease
- The Microbiome-Neuroimmune Connection
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)